BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20422498)

  • 1. Nuclear receptor regulation of the adaptive response of bile acid transporters in cholestasis.
    Wagner M; Zollner G; Trauner M
    Semin Liver Dis; 2010 May; 30(2):160-77. PubMed ID: 20422498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional regulation of hepatobiliary transport systems in health and disease: implications for a rationale approach to the treatment of intrahepatic cholestasis.
    Wagner M; Trauner M
    Ann Hepatol; 2005; 4(2):77-99. PubMed ID: 16010241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression.
    Vanwijngaerden YM; Wauters J; Langouche L; Vander Perre S; Liddle C; Coulter S; Vanderborght S; Roskams T; Wilmer A; Van den Berghe G; Mesotten D
    Hepatology; 2011 Nov; 54(5):1741-52. PubMed ID: 21800341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organic solute transporter, OSTalpha-OSTbeta: its role in bile acid transport and cholestasis.
    Soroka CJ; Ballatori N; Boyer JL
    Semin Liver Dis; 2010 May; 30(2):178-85. PubMed ID: 20422499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.
    Zollner G; Marschall HU; Wagner M; Trauner M
    Mol Pharm; 2006; 3(3):231-51. PubMed ID: 16749856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acid transporters: structure, function, regulation and pathophysiological implications.
    Alrefai WA; Gill RK
    Pharm Res; 2007 Oct; 24(10):1803-23. PubMed ID: 17404808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular bile salt transport: lessons from cholestasis.
    Trauner M; Fickert P; Stauber RE
    Can J Gastroenterol; 2000 Nov; 14 Suppl D():99D-104D. PubMed ID: 11110621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of PXR and CAR in cholestasis].
    Suh JI
    Korean J Hepatol; 2006 Mar; 12(1):5-15. PubMed ID: 16565602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New molecular insights into the mechanisms of cholestasis.
    Wagner M; Zollner G; Trauner M
    J Hepatol; 2009 Sep; 51(3):565-80. PubMed ID: 19595470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.
    Wagner M; Halilbasic E; Marschall HU; Zollner G; Fickert P; Langner C; Zatloukal K; Denk H; Trauner M
    Hepatology; 2005 Aug; 42(2):420-30. PubMed ID: 15986414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile salt excretory pump: biology and pathobiology.
    Suchy FJ; Ananthanarayanan M
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear hormone receptor-dependent regulation of hepatic transporters and their role in the adaptive response in cholestasis.
    Stahl S; Davies MR; Cook DI; Graham MJ
    Xenobiotica; 2008 Jul; 38(7-8):725-77. PubMed ID: 18668429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription.
    Li T; Chiang JY
    Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G74-84. PubMed ID: 15331348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile acid transporters and regulatory nuclear receptors in the liver and beyond.
    Halilbasic E; Claudel T; Trauner M
    J Hepatol; 2013 Jan; 58(1):155-68. PubMed ID: 22885388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of farnesoid X receptor in cholestasis.
    Yuan ZQ; Li KW
    J Dig Dis; 2016 Aug; 17(8):501-509. PubMed ID: 27383832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the enterohepatic circulation of bile salts and nuclear hormone receptors in the regulation of cholesterol homeostasis: Bile salts as ligands for nuclear hormone receptors.
    Redinger RN
    Can J Gastroenterol; 2003 Apr; 17(4):265-71. PubMed ID: 12704471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic cholestasis, causes and consequences for hepatobiliary transport.
    Jansen PL; Sturm E
    Liver Int; 2003 Oct; 23(5):315-22. PubMed ID: 14708891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond.
    Beuers U; Trauner M; Jansen P; Poupon R
    J Hepatol; 2015 Apr; 62(1 Suppl):S25-37. PubMed ID: 25920087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FXR and PXR: potential therapeutic targets in cholestasis.
    Jonker JW; Liddle C; Downes M
    J Steroid Biochem Mol Biol; 2012 Jul; 130(3-5):147-58. PubMed ID: 21801835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury.
    Stedman CA; Liddle C; Coulter SA; Sonoda J; Alvarez JG; Moore DD; Evans RM; Downes M
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2063-8. PubMed ID: 15684063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.